Jeffrey B. Landau, Chief Officer of CytomX Therapeutics CTMX, has filed 0 purchases and 5 sales on the open market. The latest trade was on 24/08/20.

JL

JL

Jeffrey B. Landau

Chief Business Officer

Company

CytomX Therapeutics CTMX

First filing

23/02/06

Trades

16 trades

Buys / sales

0 / 5

12-month net buying

No record

Last trade

24/08/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CytomX TherapeuticsCTMX	Open-market sale	24/08/20	24/08/22	4,181 sh	$1.23	$5,142.63	−3.4%
CytomX TherapeuticsCTMX	Open-market sale	24/03/19	24/03/21	6,562 sh	$2.09	$13,714.58	−5.6%
CytomX TherapeuticsCTMX	Open-market sale	23/12/20	23/12/22	4,077 sh	$1.38	$5,626.26	−4.5%
CytomX TherapeuticsCTMX	Open-market sale	23/09/22	23/09/22	4,119 sh	$1.30	$5,354.7	−5.1%
CytomX TherapeuticsCTMX	Open-market sale	23/03/16	23/03/20	1,477 sh	$1.98	$2,924.46	−2.1%